oa South African Medical Journal - Clinical evaluation of indoramin as the sole agent for the treatment of hypertension

Volume 48, Issue 37
  • ISSN : 0256-9574
  • E-ISSN: 2078-5135



An open-ended clinical trial of Indoramin (WY-21901), a new antihypertensive agent with both a-adrenergic blocking and cardio-inhibitory properties, was conducted on a group of 27 patients with mild or moderate essential hypertension.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error